Histotype
Bladder
| Parameter | Information |
|---|---|
| Strain | NSG |
| Implant Type | Cells |
| Implant Location | SC, Axilla (High) |
| Time to Staging | 14 days |
| Time to Evaluation Size (days) | 25.5 days |
| Td | 3.4 days |
The above parameters are from one study. For further information on this cell line and other parameters, including different strains, vendors, implant type and location and/or standards of care, please contact us.
Tumor Line
Mouse
Ref #
9199
Spotlight on GL261
Learn more about this cell line in our scientific spotlights:
Glioblastomas are known to have a poor prognosis with median survival of nine months and only five to 10 percent of patients surviving up to two years. Conventional therapies include radiotherapies and surgical removal of the tumor in combination with chemotherapy.